NCT00704314View on ClinicalTrials.gov

Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients?

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
HypercholesterolemiaDiabetesCardiovascular Disease
Interventions
DRUG

Simvastatin

80 mg Simvastatin daily for 8 weeks

DRUG

Placebo

The placebo was identical in appearance and was provided by the same manufacturer

Trial Locations (1)

A-1090

Medical University of Vienna, Vienna

All Listed Sponsors
collaborator

Austrian Science Fund (FWF)

OTHER

collaborator

European Foundation for the Study of Diabetes

OTHER

collaborator

EU grant

UNKNOWN

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Medical University of Vienna

OTHER

NCT00704314 - Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients? | Biotech Hunter | Biotech Hunter